SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-043997
Filing Date
2021-08-12
Accepted
2021-08-12 16:21:13
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ikna-10q_20210630.htm   iXBRL 10-Q 2293447
2 EX-31.1 ikna-ex311_6.htm EX-31.1 19072
3 EX-31.2 ikna-ex312_116.htm EX-31.2 19203
4 EX-32.1 ikna-ex321_8.htm EX-32.1 16121
  Complete submission text file 0001564590-21-043997.txt   6214763

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ikna-20210630.xsd EX-101.SCH 44559
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ikna-20210630_cal.xml EX-101.CAL 35964
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ikna-20210630_def.xml EX-101.DEF 103368
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ikna-20210630_lab.xml EX-101.LAB 327851
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ikna-20210630_pre.xml EX-101.PRE 242086
10 EXTRACTED XBRL INSTANCE DOCUMENT ikna-10q_20210630_htm.xml XML 814241
Mailing Address 50 NORTHERN AVE. BOSTON MA 02210
Business Address 50 NORTHERN AVE. BOSTON MA 02210 857-343-8292
Ikena Oncology, Inc. (Filer) CIK: 0001835579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40287 | Film No.: 211167873
SIC: 2836 Biological Products, (No Diagnostic Substances)